The CGEN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CGEN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CGEN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View CGEN Detailed Price Forecast - CNN Money | View CGEN Detailed Summary - Google Finance | ||
View CGEN Detailed Summary - Yahoo! Finance | View CGEN Stock Research & Analysis - Zacks.com |
View CGEN Trends & Analysis - Trade-Ideas | View CGEN Major Holders - Barrons | ||
View CGEN Call Transcripts - NASDAQ | View CGEN Breaking News & Analysis - Seeking Alpha | ||
View CGEN Annual Report - CompanySpotlight.com | View CGEN OTC Short Report - OTCShortReport.com | ||
View CGEN Fundamentals - TradeKing | View CGEN SEC Filings - Bar Chart | ||
View Historical Prices for CGEN - The WSJ | View Performance/Total Return for CGEN - Morningstar | ||
View the Analyst Estimates for CGEN - MarketWatch | View the Earnings History for CGEN - CNBC | ||
View the CGEN Earnings - StockMarketWatch | View CGEN Buy or Sell Recommendations - MacroAxis | ||
View the CGEN Bullish Patterns - American Bulls | View CGEN Short Pain Metrics - ShortPainBot.com |
View CGEN Stock Mentions - StockTwits | View CGEN Stock Mentions - PennyStockTweets | ||
View CGEN Stock Mentions - Twitter | View CGEN Investment Forum News - Investor Hub | ||
View CGEN Stock Mentions - Yahoo! Message Board | View CGEN Stock Mentions - Seeking Alpha |
View Insider Transactions for CGEN - SECform4.com | View Insider Transactions for CGEN - Insider Cow | ||
View CGEN Major Holdings Summary - CNBC | View Insider Disclosure for CGEN - OTC Markets | ||
View Insider Transactions for CGEN - Yahoo! Finance | View Institutional Holdings for CGEN - NASDAQ |
View CGEN Stock Insight & Charts - FinViz.com | View CGEN Investment Charts - StockCharts.com | ||
View CGEN Stock Overview & Charts - BarChart | View CGEN User Generated Charts - Trading View |
Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024
Posted on Monday May 06, 2024
Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that the Company will release its first quarter 2024 financial results on Monday, May 20, 2024, before the U.S. financial markets open. Management will host a conference call and webcast to review the results and provide a corporate update at 8:30 AM ET.
We're Not Worried About Compugen's (NASDAQ:CGEN) Cash Burn
Posted on Monday April 29, 2024
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, Compugen...
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024
Posted on Thursday April 25, 2024
Compugen Ltd. (NASDAQ: CGEN) (TASE:CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that it will present new clinical data on COM701 (anti-PVRIG) in triple combination with COM902 (anti-TIGIT) and pembrolizumab in microsatellite stable colorectal cancer at the American Society of Clinical Oncology (ASCO) annual meeting on May31-June 4 2023, in Chicago, Illinois.
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
Posted on Wednesday April 10, 2024
Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the simultaneous online publication of a peer reviewed paper titled 'Unleashing natural IL-18 activity using an anti-IL-18BP blocker antibody induces potent immune stimulation and anti-tumor effects' link, in Cancer Immunology Research, a journal of the American Association for Cancer Research with a presentation at the American Association for